Results 1 to 10 of about 6,579 (240)

Transarterial radioembolization for hepatocellular carcinoma: a review [PDF]

Journal of Hepatocellular Carcinoma, 2016
Rodolfo Sacco,1 Caterina Conte,2 Emanuele Tumino,1 Giuseppe Parisi,1 Sara Marceglia,3 Salvatore Metrangolo,1 Roberto Eggenhoffner,4 Giampaolo Bresci,1 Giuseppe Cabibbo,5 Luca Giacomelli4 1Department of Gastroenterology, Cisanello Hospital, Pisa ...
Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L   +9 more
doaj   +8 more sources

Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres [PDF]

Diagnostics, 2023
Background: Transarterial Radioembolization (TARE) is an effective treatment option for both primary and secondary liver malignancies. However, challenging anatomical conditions can lead to prolonged fluoroscopy times (FT), elevated doses of ...
Constantin Ehrengut, Johanna Vogt, Jakob Leonhardi, Emma Carabenciov, Felix Teske, Florian van Boemmel, Thomas Berg, Daniel Seehofer, Thomas Lincke, Osama Sabri, Holger Gößmann, Timm Denecke, Sebastian Ebel   +12 more
doaj   +4 more sources

An Unusual Complication of Transarterial Radioembolization: Hepatic Artery Pseudoaneurysm and its Treatment with Ultrasound-guided Thrombin Injection [PDF]

The Arab Journal of Interventional Radiology, 2023
Transarterial radioembolization (TARE) is a widely used treatment method for primary liver cancers and metastasis. Although TARE is relatively safe, it may cause liver abscess, failure, nontarget embolization, and vascular complications.
Muhammet Arslan, Halil Serdar Aslan, Burak Sarılar, Aziz Gültekin   +3 more
doaj   +2 more sources

Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization [PDF]

Radiology Case Reports, 2018
The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization.
Sriharsha Gummadi, MD, Maria Stanczak, MS, RDMS, RVT, Andrej Lyshchik, MD, PhD, Flemming Forsberg, PhD, Colette M. Shaw, MD, John R. Eisenbrey, PhD   +5 more
doaj   +3 more sources

Efficacy and Safety of Transarterial Radioembolization in Elderly Patients with Hepatocellular Carcinoma: A Single-Center Experience [PDF]

The Turkish Journal of Gastroenterology
Background/Aims: Hepatocellular carcinoma is a major cause of mortality and morbidity in both cirrhotic and non-cirrhotic patients, and most patients are suitable for locoregional and/or systemic therapy at the time of diagnosis.
Ümit Karaoğullarından, Yüksel Gümürdülü, Oğuz Üsküdar, Emre Odabaş, Hasan Selim Güler, Cansu Geçkalan, Burcu Aslan Benli, Anıl Delik , Asena Ayça Özdemir, Sedef Kuran   +9 more
doaj   +2 more sources

Transarterial Radioembolization for Hepatocellular Carcinoma in Korea: Current Clinical Practices, Facility Requirements, and Patient Selection [PDF]

Journal of the Korean Society of Radiology
Before initiating Yttrium-90 (90Y) radioembolization, both the interventional radiology and nuclear medicine departments must prepare facilities for radionuclide handling, implement appropriate radiation protection and monitoring measures, and ensure ...
Dongho Hyun
doaj   +2 more sources

Impact of Preoperative Yttrium-90 Transarterial Radioembolization on Patients Undergoing Right or Extended Right Hepatectomy for Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Fontana AP, Russolillo N, Maurino L, Marengo A, Calvo A, Ricotti A, Langella S, Tesoriere RL, Ferrero A.   +8 more
europepmc   +3 more sources

Yttrium-90 Transarterial Radioembolization as a Bridging Therapy to Liver Transplant in a Toddler With Pretreatment Extent (PRETEXT) IV Hepatoblastoma. [PDF]

Cureus
Rehder J, Desai J, Goode T, Rudder W, Fox J, Anderson K, Wilder A, Fleetwood V, Kao J, Vaheesan K, Varma CR, Jain A, Nazzal M.   +12 more
europepmc   +3 more sources

Contrast-enhanced CT as a non-invasive alternative for lung shunt fraction estimation in hepatic transarterial radioembolization. [PDF]

Radiol Adv
Mehadji B, Marx T, Carter A, Goldman RE, Vu CT, Roncali E.   +5 more
europepmc   +3 more sources

Voxel-based dosimetry for predicting treatment response to transarterial radioembolization in hepatocellular carcinoma: significance of intratumoral dose distribution. [PDF]

EJNMMI Phys
Suh M, Kim KM, Choi JW, Lee JS, Paeng JC, Kim HC.   +5 more
europepmc   +2 more sources